Expanding the Spectrum of Perioral Myogenic Tumors in Pediatric Patients: An SRF::NCOA2 Fused Perivascular Tumor of the Philtrum

Pediatr Dev Pathol. 2023 Jan-Feb;26(1):65-71. doi: 10.1177/10935266221138896. Epub 2022 Dec 1.

Abstract

Background: Perivascular tumors, which include myopericytoma and myofibroma, are rare benign soft tissue neoplasms composed of perivascular smooth muscle cells. Most demonstrate characteristic morphology and are readily diagnosed. However, a recently identified hypercellular subset shows atypical histologic features and harbor unique SRF gene fusions. These cellular perivascular tumors can mimic other more common sarcomas with myogenic differentiation.

Methods: Clinical, radiological, morphological, immunohistochemical, and molecular findings were reviewed.

Results: A slow-growing, fluctuant mass was noted within the philtrum at 16 months. Ultrasonography revealed a well-circumscribed cystic hypoechoic lesion. A small (1.0 cm), tan, well-circumscribed soft-tissue mass was excised after continued growth. Histologically, the encapsulated tumor was hypercellular and composed of spindle cells with predominantly-storiform architecture, focal perivascular condensation, dilated branching thin-walled vessels, increased mitoses, and a smooth muscle immunophenotype. An SRF::NCOA2 fusion was identified.

Conclusion: We report the first case of an SRF-rearranged cellular myopericytoma in the perioral region in a young child. This case expands the differential diagnosis of perioral soft tissue tumors with myogenic differentiation. We highlight key clinical, pathological, and molecular features. As we illustrate, these rare tumors pose a considerable diagnostic challenge, and risk misdiagnosis as sarcoma, most notably spindle cell rhabdomyosarcoma.

Keywords: SRF-fused tumors; SRF::NCOA2; myopericytoma; pediatric; perivascular tumor; soft tissue tumors.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biomarkers, Tumor / genetics
  • Child
  • Humans
  • Lip / pathology
  • Myofibromatosis*
  • Myopericytoma*
  • Nuclear Receptor Coactivator 2
  • Sarcoma* / genetics
  • Soft Tissue Neoplasms* / diagnosis
  • Soft Tissue Neoplasms* / genetics
  • Soft Tissue Neoplasms* / pathology

Substances

  • Biomarkers, Tumor
  • NCOA2 protein, human
  • Nuclear Receptor Coactivator 2